Log in
Rheumatology

2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis

EULAR2021Full text
Full text · CC BYNikiphorou E, Santos EJF, Marques A, Böhm P, Bijlsma JW, Daien CI et al.. 2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis. Ann Rheum Dis, 2021. Licensed under CC BY. Changes: reformatted for the web. Original: https://doi.org/10.1136/annrheumdis-2021-220249

Summary

Background

An important but often insufficient aspect of care in people with inflammatory arthritis (IA) is empowering patients to acquire a good understanding of their disease and building their ability to deal effectively with the practical, physical and psychological impacts of it. Self-management skills can be helpful in this regard.

Objectives

To develop recommendations for the implementation of self-management strategies in IA.

Methods

A multidisciplinary taskforce of 18 members from 11 European countries was convened. A systematic review and other supportive information (survey of healthcare professionals (HCPs) and patient organisations) were used to formulate the recommendations.

Results

Three overarching principles and nine recommendations were formulated. These focused on empowering patients to become active partners of the team and to take a more proactive role. The importance of patient education and key self-management interventions such as problem solving, goal setting and cognitive behavioural therapy were highlighted. Role of patient organisations and HCPs in promoting and signposting patients to available resources has been highlighted through the promotion of physical activity, lifestyle advice, support with mental health aspects and ability to remain at work. Digital healthcare is essential in supporting and optimising self-management and the HCPs need to be aware of available resources to signpost patients.

Conclusion

These recommendations support the inclusion of self-management advice and resources in the routine management of people with IA and aim to empower and support patients and encourage a more holistic, patient-centred approach to care which could result in improved patient experience of care and outcomes.

Introduction

In people living with inflammatory arthritis (IA), as well as other rheumatic and musculoskeletal diseases (RMDs) and chronic conditions, an important aspect of care is the ability to understand the disease and deal with the practical, physical and psychological impacts that come along with it.1 2 This extends beyond drug therapy and places emphasis on the ability to self-manage as an essential component of care.3 Comorbidities including cardiovascular disease and common mental health conditions represent important, yet often poorly addressed aspects of IA despite their impact on disease outcomes.4 5 Addressing physical as well as psychological comorbidities is therefore crucial and more likely to be achieved if more holistic approaches to patient care are adopted, including, for example, signposting, where appropriate, to other members of the multidisciplinary team (MDT).6 These members include, aside from rheumatologists, nurses, physiotherapists, occupational therapists, podiatrists, psychologists, nutritionists and any other healthcare professionals (HCPs) involved in the care of patients with IA.2 All these important aspects of disease which can place a high burden on the individual and their immediate family necessitate the incorporation of supported self-management in the routine clinical care of people living with IA. For self-management to be effective however, it is imperative that HCPs (for the purposes of this work, reference to HCPs includes rheumatologists as well as allied health professionals) are given adequate guidance and professional training. This has a significant positive impact on their engagement in clinical self-management support and patient centredness, as well as on their overall confidence to support self-management.7 Patient organisations also play a role in the provision of supported self-management resources. Acknowledging all these important aspects of care, a taskforce supported by the European Alliance of Associations for Rheumatology (EULAR) was convened to embed recommendations alongside the standard medical care of IA that encourage supported patient self-management and concordance with treatment.

The overarching aim of the taskforce was to formulate recommendations for the implementation of self-management strategies in patients with IA, including but not limited to rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis. The target audience was HCPs including all members of the MDT and patients. There were three key objectives: (1) to develop EULAR recommendations for the implementation of effective self-management strategies facilitated by HCPs in IA concurrently with and complimentary to the delivery of standard medical care, (2) to enable all members of the rheumatology MDT to be able to provide and signpost a continuous and appropriate measure of support to enable better self-management of patient with IA and (3) to improve the patient’s ‘journey’ and experience during their care, disease outcomes and quality of life.

Methods

The 2014 updated EULAR standardised operating procedures were followed throughout the execution of this work.8 Following approval by the EULAR Executive Committee, the convenors (AB, EN) and methodologist (LC) led a taskforce of 18 members from across 11 European countries. Taskforce members came with a background and expertise in rheumatology, nursing, occupational therapy, psychology, self-management, exercise physiology and physiotherapy. The taskforce also included patient representatives with lived experience of IA from People with Arthritis/Rheumatism across Europe. Expert discussions took place primarily through two taskforce meetings, the first, face-to-face and the second, via a virtual online platform.

In preparation for the first meeting, an initial scoping review and a survey (available on request) were undertaken to explore, respectively, effective interventions in IA and self-management resources in RMDs across Europe. During the first meeting, the scope of this work, definitions for self-management and overarching principles (OAPs) were discussed. Furthermore, unmet need and key clinically relevant questions were identified in relation to self-management in IA and sources of best practice examples explored.

In preparation for the second meeting and, as guided by the first meeting, clinical questions were converted by the steering group (AB, EN, LC, AM, EJFS) into epidemiological questions that were addressed through systematic literature review (SLR) (under submission) undertaken by the taskforce fellows (AM, EJFS). The aim of the SLR was to identify the best evidence for the implementation of self-management interventions in IA and to describe individual components and effects. The review was conducted according to the Cochrane Handbook9 and reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.10 Patient organisations affiliated with EULAR and HCPs across Europe were also approached via direct email communication requesting information and experience/feedback on examples of self-management resources in IA, to supplement the information retrieved from the SLR.

At the second meeting, the taskforce members formulated the OAPs and recommendations based on evidence from the SLR, survey, email communication with patient organisations/HCPs and best practice examples, guided by their expert opinion and through a process of discussion and voting. Consensus was accepted in the first round if >75% of the members voted in favour of keeping it in. In the second and third rounds, after refinements, the level of agreement (LoA) was voted on a 0 to 10 scale (0=‘do not agree at all’ to 10=‘fully agree’) anonymously. The second round was voted through Zoom polls during the second meeting and the third round through SurveyMonkey, afterwards. The mean and SD of the LoA was presented along with the percentage of taskforce members with an agreement ≥8. An indication of the level of evidence (LoE) based on the evidence retrieved from the SLR was discussed for each of the formulated recommendations, to facilitate discussions. At the meeting, the LoE and strength of recommendation were assigned for each of the final drafted recommendations using the standards of the Oxford Centre for Evidence Based Medicine.11

Finally, a research agenda was formulated based on discussions around identified unmet need and gaps in evidence.

Results

The taskforce discussed existing definitions for self-management and reached consensus on three OAPs and nine recommendations (table 1), guided by the results of the SLR, the surveys to patient organisations and HCPs relating to self-management resources, across EULAR countries (online supplemental file) and best practice examples (can be provided on request). In total, 12 patient organisations were approached of which 9 responded, representing eight different countries. A total of 13 HCPs were approached and 100% replied from 13 different countries.

Table 1

EULAR overarching principles (OAPs) and recommendations for the implementation of self-management strategies in patients with inflammatory arthritis (IA)

LoE
(1–5)		SoR (A–D)Level of agreement
(0–10)
Mean (SD)% with score ≥8
OAPs 
A. Self-management implies taking an active role in learning about one’s condition and in the shared decision-making process about one’s health and care pathway.n.an.a9.5 (0.6)100
B. Self-efficacy (personal confidence to carry out an activity with the aim of achieving a desired outcome) has a positive effect on various aspects of living with IA.n.an.a9.6 (0.7)100
C. Patient organisations often provide valuable self-management resources and collaboration between healthcare professionals (HCPs) and patient organisations will therefore benefit patients.n.an.a9.4 (1.0)88
Recommendations 
R1. HCPs should encourage patients to become active partners of the team and make them aware of HCPs and patient organisations involved in all aspects of the care pathway.5D9.5 (1.1)87
R2. Patient education should be the start point and underpin all self-management interventions.1AA9.5 (0.8)93
R3. Self-management interventions that include problem solving and goal setting and, where relevant to the individual and available, cognitive behavioural therapy should be incorporated into routine clinical practice to support patients.1AA9.1 (1.4)93
R4. HCPs should actively promote physical activity at diagnosis and throughout the disease course.1AA9.9 (0.3)100
R5. Lifestyle advice based on evidence should be given to better manage common comorbidity and patients should be guided and encouraged by their healthcare team to adopt healthy behaviours.5D9.6 (0.6)100
R6. Better emotional well-being leads to better self-management; therefore, mental health needs to be assessed periodically and appropriate intervention should be made if necessary.5D9.4 (1.3)93
R7. HCPs should invite discussion with patients about work and signpost to sources of help where appropriate or where needed.5D9.6 (0.5)100
R8. Digital healthcare can help patients to self-manage and should be considered for inclusion in supported self-management where appropriate and available.1BA9.3 (1.0)93
R9. HCPs should make themselves aware of available resources to signpost patients to, as part of optimising and supporting self-management.5D8.7 (1.2)100

EULAR, European Alliance of Associations for Rheumatology; LoE, level of evidence (1–5; 1 indicating evidence from high-quality randomised clinical trial (RCT) data and 5 indicating evidence from expert opinion without explicit critical appraisal or based on physiology, bench research or ‘first principles’)11; n.a, not applicable; SoR, strength of recommendation (A–D; A indicating consistent level 1 studies (RCTs) and D indicating level 5 evidence or troublingly inconsistent or inconclusive studies of any level).

Definition

The definition and concept of self-management varies widely in the published literature and the context in which it is used.12 The taskforce aligned mostly with the well-established definition of self-management provided by Barlow et al 13 whereby self-management is defined as ‘the ability of the individual to manage symptoms, treatment, lifestyle changes and psychosocial and cultural consequences of health conditions’. In this definition, two major components were highlighted: (1) self-management is aimed at achieving independence and (2) ideally, self-management should be supported by others, for example, HCPs, patient organisations and family. The taskforce proposed to emphasise the important contribution that patient organisations can make in supporting self-management for the purpose of this work and any future reference on the topic, something that has been largely overlooked and left out of most definitions to date.

Overarching principles

The taskforce identified key themes considered to apply across all recommendations, formulated and agreed as three OAPs.

  1. Self-management implies taking an active role in learning about one’s condition and in the shared decision-making process about one’s health and care pathway.

    Driven by the self-management definition above, it is important that patients take an active role in understanding their condition and engage in acquiring self-management skills and coping strategies, as well as in shared decision-making, as part of their care. Effective supported self-management encompasses the ability to monitor one’s condition and to put into action the cognitive, behavioural and emotional responses necessary to maintain a satisfactory quality of life.14–17 This way, a dynamic and continuous process of self-regulation is established. The importance of targeting and educating HCPs on self-management strategies and available resources, to ensure their ability to provide optimal support to patients, has been strongly emphasised.

  2. Self-efficacy (personal confidence to carry out an activity with the aim of achieving a desired outcome) has a positive benefit on various aspects of living with IA.

    Good self-efficacy and coping skills benefit and reduce health and financial burden to the individual as well as the health service, benefitting society overall.18 19 Self-efficacy, supported by the existing literature, implies a process as well as an outcome20 since it is also an important outcome of self-management interventions.1

  3. Patient organisations often provide valuable self-management resources and collaboration between HCPs and patient organisations may therefore benefit patients.

    There are numbers of best practice examples which include self-management resources in Europe, with important benefits for patients. Aside from practical advice and physical support, patient organisations can provide support with mental health issues, self-isolation and loneliness,21 which commonly feature in patients with IA. HCPs should take responsibility for addressing these issues in people living with IA and signpost to patient organisations. The taskforce acknowledges that variation exists both in healthcare delivery and the resources that patient organisations can offer. In some countries such as the UK, patient organisations invite HCPs to become medical advisors to the organisation and also provide free membership to all HCPs. Their medical advisors actively contribute educational articles for their magazines and to patient-related campaigns, educational activities and others. There is a close relationship that encourages cross-talk and collaboration that can be of huge benefit to patients.

Recommendations

R1. HCPs should encourage patients to become active partners of the team and make them aware of HCPs and patient organisations involved in all aspects of the care pathway

For patients to take a more active role in their health, it is important that they are introduced to all members of the MDT involved in all aspects of their disease. Patient organisations can provide an invaluable source of information and resources to support patients. Yet, there seems to be a general lack of awareness of the self-management resources (and potential value) provided by many patient organisations (eg, in terms of patient education/disease knowledge, advocacy and other resources) and hence referral to these resources by HCPs. Some patients already engage in self-management and reach out to patient organisations for support. We acknowledge that patient organisations or at least well-developed patient organisations are not always available in many parts of Europe. Where available, patients should be signposted to relevant patient organisations in parallel with all other care and treatment they may be receiving.22 23 Where not available, we recommend using existing sources of information from the websites of other patient organisations and generally from trusted internet information sites, books and any other educational material that may be easily accessible online or via other routes.

R2. Patient education should be the start point and underpin all self-management interventions

Specific interactive education was among the most studied intervention across 19 randomised clinical trials (RCTs) based on the findings of the systematic review informing this taskforce (under submission). Self-management is considered a complex intervention as it contains many interacting techniques, thus making it difficult to identify the most effective components.18 Patient education is considered crucial, but not sufficient, in the context of self-management and is included in a majority of interventions.24–30 Patient education has been shown to improve treatment adherence, based on clinical trial evidence, although patient sample and follow-up time were both limited.26 The taskforce considers treatment adherence (and discussions addressing this) to be part of the patient education plan.31 Patient organisations reinforce the information and messaging about adherence and the impact of peer reinforcement around adherence is very powerful.

EULAR has produced recommendations for patient education for people with IA addressing when and by whom patient education should be offered, as well as modes and methods of delivery, theoretical frameworks, outcomes and evaluation.32 We advocate the use of these recommendations when it comes to patient education, recognising that patient education is an integral part of supported self-management for people with IA throughout the course of their disease.

R3. Self-management interventions that include problem solving and goal setting and, where relevant to the individual and available, cognitive behavioural therapy (CBT), should be incorporated into routine clinical practice to support patients

There are various self-management interventions. These include problem solving27 29 30 33–39 and goal setting,27 29 30 33 34 37 39 as well as cognitive behavioural therapy (CBT),28 33 35 37–41 supported by several SLRs and RCTs. The three interventions highlighted in this recommendation were therefore supported by strong evidence in their role in self-management. We advocate that they are promoted and provided where available and are relevant to patients, to enhance their ability to manage their disease confidently.42 CBT is a psychosocial intervention, often delivered by psychologists/psychotherapists, but also by some nurse specialists who have done a course in CBT and this further highlights the important role of the MDT. Referral to CBT can be initiated by any HCP involved in the care of the patient, if any doubt, in liaison with an expert delivering the intervention.

R4. HCPs should actively promote physical activity at diagnosis and throughout the disease course

Ample evidence from the existing literature supports the use of physical activity in IA and demonstrates its beneficial effect on several outcomes.43–49 Existing EULAR recommendations on physical activity50 emphasise its importance in disease management, based on proven effectiveness, feasibility and safety. Physical activity should thus form an integral part of standard patient care and be actively promoted and tailored to the individual’s circumstances, throughout their disease course. HCPs should be aware of the benefits of physical activity and advocate this as an important component of self-management. Any HCP should be able to promote the benefits of being physically active and take regular exercise and initiate a referral for physical therapy if deemed appropriate. If discussion is required with a physiotherapist or other physical exercise expert regarding the need and type of physical activity appropriate for an individual, then HCPs should know whom to approach for this. While there is a considerable amount of evidence for the beneficial effects of exercise, there is a general lack of emphasis on this aspect of care. Most interventions in regard to exercise relate to referral to a physiotherapist. However, the taskforce emphasises the importance and potential of exercise programmes and information provided by patient organisations and other community programmes, for example, classes which might include physical activities such as aquarobics, swimming, dancing, yoga and pilates.51

R5. Lifestyle advice based on evidence should be given to better manage common comorbidity and patients should be guided and encouraged by their healthcare team to adopt healthy behaviours

A number of modifiable lifestyle factors in IA can affect outcome.52 For example, the negative effects of smoking53 as well as high body mass index54 impact on inflammation and disease activity are now well established, as is the increased risk of cardiovascular disease.55 Lifestyle approaches should complement medical treatments, as also supported by a EULAR taskforce dedicated to providing recommendations on specific lifestyle interventions for the management of RMDs (currently ongoing). This taskforce considers such interventions to be a core part of self-management and advocates that patients receive support to adopt healthy behaviours including guidance on what constitutes a healthy, balanced diet, the benefits of exercise and quitting smoking, among others. Where specialised input is needed, for example, on nutrition, the input from dieticians should be sought where possible, acknowledging that dieticians are not always ‘standard’ members of the MDT so external support might be required. Such interventions are expected to have a positive impact on comorbidities and extra-articular manifestations, as well as the IA itself and should be accompanied by relevant investigations such as lipid profile testing, blood pressure monitoring and sleep hygiene.4 6 56 57 The addressing of comorbidities and initiation of relevant investigations may be undertaken by primary care physicians, rheumatologists or other HCPs such as nurses, involved in the patient’s care and as part, for example, of an annual review clinic. Some centres have their own pro formas for screening of comorbidities or lifestyle factors, for example, smoking, and these can be helpful as part of the screening process and facilitate the process for any member of the MDT.

R6. Better emotional well-being leads to better self-management; therefore, mental health needs to be assessed periodically and appropriate intervention be made if necessary

Poor mental health leads to worse outcomes in IA.58–60 CBT and other psychosocial interventions43 61–64 should be offered where available and tailored according to individual needs. Addressing mental health issues can help mitigate self-isolation and feelings of loneliness and can result in better self-management.59 65 Examples of questionnaires that could be used to measure patients’ emotional well-being feasibly in routine clinical practice include the mental health component of the SF3666 and the Patient Health Questionnaire (PHQ-9).67 The taskforce acknowledges that many patient organisations provide forums for networking and peer support programmes which can improve emotional well-being. Furthermore, we acknowledge that patients requiring more specialist assessment and support for mental health issues should be signposted as necessary, for example, to psychology and/or psychiatry.

R7. HCPs should invite discussion with patients about work and signpost to sources of help where appropriate or where needed

EULAR’s current strategy states that ‘by 2023, EULAR’s activities and related advocacy will have increased participation in work by people with RMDs’.68 The greatest proportion of people with IA are of working age at the time of diagnosis and work represents a major contributor to financial independence, self-esteem, purpose in life and overall quality of life.2 69 70 Therefore, it is crucial to the taskforce that HCPs address work-related aspects and signpost the patients to useful resources and support them to stay in work and maintain their independence.71 Occupational therapists and occupational health experts can provide helpful advice and resources in relation to the workplace.

R8. Digital healthcare can help patients to self-manage and should be considered for inclusion in supported self-management, where appropriate and available

Electronic patient records and other digital resources such as mobile health apps are becoming increasingly available in healthcare delivery.72 Mobile health technologies in particular can support self-management and allow people to take a more active role in their health.72 73 Patient-reported outcome domains as deemed relevant and important by patients could also be considered with digital healthcare. EULAR recommendations provide guidance on important aspects that should be considered for the development, evaluation and implementation of existing and new apps.74 The taskforce recommends referring to EULAR guidance on the above.

R9. HCPs should make themselves aware of available resources to signpost patients to, as part of optimising and supporting self-management

The taskforce highlighted the need for HCPs to be made aware of available resources for patients with IA, including those provided by patient organisations, to promote and support self-management interventions. At the same time, the taskforce recognised that just as there’s variation in healthcare resources, there is also variation in what patient organisations can offer.75

Discussion

This EULAR taskforce has produced three OAPs relevant to nine agreed recommendations for the implementation of supported self-management strategies in patients with IA. OAPs and recommendations were met with strong consensus among experts in the task force.

The concept of self-management to some may imply needing to deal alone with a chronic condition.76 Receiving adequate support from a variety of sources is crucial.77 A key role of HCPs is also to enable access to and to signpost to supported self-management resources. Many HCPs will need to make themselves aware of how to most effectively provide and signpost to these different resources. The taskforce highlighted the importance of honesty and building trust as important elements for establishing open communication between patients and HCPs.78–81 Adequate time should be given to patients, as well as family and carers to discuss concerns and management options.82 83 Forward planning should be based on goal setting and what matters to patients, as supported by the existing literature.27 29 30 33 34 37 39 Furthermore, it was recognised that context, in other words, health system, culture or local resources, vary across settings and that nothing can be implemented without a clear familiarity and understanding of the local context. It is therefore important to understand and appreciate individual circumstances and social context when it comes to patient care, to maximise chances of implementing proposed care and supported self-management plans.84 85 For example, potential barriers to effective engagement with self-management could include poor health literacy and cultural or personal barriers, for example, for the latter, language barriers and low education. These should be identified where possible to maximise the support given to patients and to enhance their overall participation in self-management strategies. In some countries, patient organisations are particularly influential and with well-developed, active websites, support lines, educational material and some even with self-management programmes already established and made available to patients, families and carers. We encourage the use of social media such as Facebook, Twitter, websites and advertisements, for example, on national TV/radio to promote these resources.

Exploration of various definitions of self-management by the task force indicated that more holistic definitions of self-management reflecting the ‘individual’s ability to manage symptoms, treatment, physical and psychosocial consequences and lifestyle changes inherent in living with a chronic condition’ were more warmly received.3 The taskforce additionally highlighted the important contribution that patient organisations can make in supporting self-management, an aspect that has been largely left out of definitions to date. The latter is supported by additional sources of evidence informing this task force including direct communication with chief executives of patient organisations and best practice examples (available on request). However, the taskforce noted that the constitution of patient organisations varies considerably from large professional expert organisations led by paid chief executive officers and staff governed by boards of trustees to very small organisations which are primarily volunteer led. This means that the resources provided by patient organisations also vary.

Patient education has been identified as a crucial component that should underpin all self-management interventions. Effective patient education should be the responsibility of both the HCPs and the patients themselves. Patient education has been shown to improve treatment adherence,26 something that this taskforce recognises as an important part of patient education. Furthermore, patient outcomes including effective disease knowledge, healthcare management and self-efficacy have been shown to improve with patient education.24–30

The vision of the taskforce is that patient–HCP communication, the setting of meaningful and achievable goals and shared decision-making are seen as core components of self-management. This aligns well with EULAR’s current quality-of-care strategy that by 2023, EULAR will deliver pre-eminent comprehensive quality of care frameworks for the management of people with RMDs. One of the main quality-of-care objectives is to provide a ‘package’ that will enable greater uptake of the advice given in the recommendations, in other words emphasis on implementation aspects.68 In this regard and in relation to the nine recommendations, the taskforce recognised the importance of:

  1. Raising awareness and educating HCPs on self-management strategies and available resources, to ensure ability to provide optimal support to patients.
  2. Efforts to increase awareness and strengthen collaborations between patients, patient organisations and HCPs.
  3. Signposting patients to good evidence-based information, also provided by many patient organisations.
  4. Patient education as a crucial component of self-management, while acknowledging that being educated around various aspects of the disease does not necessarily imply implementation of meaningful changes.

It was particularly highlighted that training of HCPs, for example, on CBT, can improve their skills to deliver interventions and can be of great benefit to patients.28 33 35 37–41 The taskforce emphasised the need and importance of members of the MDT to be encouraged to work as a team towards implementation of the specific recommendations. Knowledge sharing should form a core part of these MDT meetings. Additionally, individual needs and variation in national health systems, availability of local resources and patient organisation offerings should be considered as part of the implementation. Finally, it is important to keep in mind that for self-management to be effective, the mode of delivery of various interventions should be considered in the setting of disease and severity, individual social circumstances and available resources. Referral to occupational health, occupational therapy patient organisations for resources related to work issues and other support should be considered where indicated and available.

With the recognition of all the above, unmet need has been identified and a research agenda has been proposed (box 1) for future work on the subject. An important focus has been the value of patient organisations and information and other resources they can provide to support people with IA, as well as the need to demonstrate and document the effectiveness of specific self-management interventions. It is particularly challenging for patient organisations to demonstrate the value of what they do, however, this does not remove the need for them to make real effort to demonstrate the impact of their resources. The taskforce identified, as part of the educational agenda, that there is scope for using best practice self-management programme examples to encourage and support other less-developed patient organisations and healthcare systems to work towards developing similar patient resources. Furthermore, in current clinical practice there is a strong emphasis on achieving clinical markers that are of importance to HCPs, for example, lowering of disease activity, whereas this taskforce is advocating that more focus should be given to goals that are more meaningful to the patients in the context of their everyday lives. In this respect, we recommend raising awareness among HCPs of the importance of the biopsychosocial determinants of health.

Conclusions

In conclusion, EULAR recommendations are now available for the implementation of self-management strategies in patients with IA. A dissemination strategy is currently underway to enhance the uptake of these recommendations, through national organisations, patient organisations and educational programmes.

References

  1. Martinez-Calderon J , Meeus M , Struyf F , et al . The role of self-efficacy in pain intensity, function, psychological factors, health behaviors, and quality of life in people with rheumatoid arthritis: a systematic review . Physiother Theory Pract 2020 ; 36 : 21 – 37 . 10.1080/09593985.2018.1482512 29873569 DOI PubMed
  2. Santos EJF , Duarte C , Ferreira RJO , et al . Determinants of Happiness and quality of life in patients with rheumatoid arthritis: a structural equation modelling approach . Ann Rheum Dis 2018 ; 77 : 1118 – 24 . 10.1136/annrheumdis-2017-212934 29625967 PMC6059049 DOI PubMed
  3. Barlow J , Wright C , Sheasby J , et al . Self-Management approaches for people with chronic conditions: a review . Patient Educ Couns 2002 ; 48 : 177 – 87 . 10.1016/S0738-3991(02)00032-0 12401421 DOI PubMed
  4. Baillet A , Gossec L , Carmona L , et al . Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative . Ann Rheum Dis 2016 ; 75 : 965 – 73 . 10.1136/annrheumdis-2016-209233 26984008 DOI PubMed
  5. Chen L , Li W , He J , et al . Mental health, duration of unemployment, and coping strategy: a cross-sectional study of unemployed migrant workers in eastern China during the economic crisis . BMC Public Health 2012 ; 12 : 597 . 10.1186/1471-2458-12-597 22856556 PMC3490784 DOI PubMed
  6. Dougados M , Soubrier M , Antunez A , et al . Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA) . Ann Rheum Dis 2014 ; 73 : 62 – 8 . 10.1136/annrheumdis-2013-204223 24095940 PMC3888623 DOI PubMed
  7. Mudge S , Kayes N , McPherson K . Who is in control? clinicians' view on their role in self-management approaches: a qualitative metasynthesis . BMJ Open 2015 ; 5 : e007413 . 10.1136/bmjopen-2014-007413 PMC4431068 25943372 DOI PubMed
  8. van der Heijde D , Aletaha D , Carmona L , et al . 2014 update of the EULAR standardised operating procedures for EULAR-endorsed recommendations . Ann Rheum Dis 2015 ; 74 : 8 – 13 . 10.1136/annrheumdis-2014-206350 25261577 PMC4283681 DOI PubMed
  9. Higgins JPT , Thomas J , Chandler J . Cochrane Handbook for systematic reviews of interventions version 6.0 (updated July 2019): cochrane; , 2019 . Available: www.training.cochrane.org/handbook
  10. Moher D , Liberati A , Tetzlaff J , et al . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement . PLoS Med 2009 ; 6 : e1000097 . 10.1371/journal.pmed.1000097 19621072 PMC2707599 DOI PubMed
  11. Cebm . Oxford centre for evidence-based medicine. levels of evidence (updated in 2012) , 2009 . Available: https://www.cebm.ox.ac.uk/resources/levels-of-evidence/oxford-centre-for-evidence-based-medicine-levels-of-evidence-march-2009
  12. Rogers A , Kennedy A , Nelson E , et al . Uncovering the limits of patient-centeredness: implementing a self-management trial for chronic illness . Qual Health Res 2005 ; 15 : 224 – 39 . 10.1177/1049732304272048 15611205 DOI PubMed
  13. Barlow JH , Williams B , Wright CC . Patient education for people with arthritis in rural communities: the UK experience . Patient Educ Couns 2001 ; 44 : 205 – 14 . 10.1016/S0738-3991(00)00196-8 11553421 DOI PubMed
  14. Kao M-J , Wu M-P , Tsai M-W , et al . The effectiveness of a self-management program on quality of life for knee osteoarthritis (oa) patients . Arch Gerontol Geriatr 2012 ; 54 : 317 – 24 . 10.1016/j.archger.2011.05.018 21726907 DOI PubMed
  15. Magharei M , Jaafari S , Mansouri P , et al . Effects of self-management education on self-efficacy and quality of life in patients with ulcerative colitis: a randomized controlled clinical trial . Int J Community Based Nurs Midwifery 2019 ; 7 : 32 – 42 . 30643831 10.30476/IJCBNM.2019.40844 PMC6311208 PubMed DOI
  16. Benzo RP , Abascal-Bolado B , Dulohery MM . Self-Management and quality of life in chronic obstructive pulmonary disease (COPD): the mediating effects of positive affect . Patient Educ Couns 2016 ; 99 : 617 – 23 . 10.1016/j.pec.2015.10.031 26632024 PMC4808334 DOI PubMed
  17. Kvien TK , Balsa A , Betteridge N , et al . Considerations for improving quality of care of patients with rheumatoid arthritis and associated comorbidities . RMD Open 2020 ; 6 : e001211 . 10.1136/rmdopen-2020-001211 32683326 PMC7722279 DOI PubMed
  18. Manning VL , Kaambwa B , Ratcliffe J , et al . Economic evaluation of a brief education, self-management and upper limb exercise training in people with rheumatoid arthritis (extra) programme: a trial-based analysis . Rheumatology 2015 ; 54 : 302 – 9 . 10.1093/rheumatology/keu319 25173349 DOI PubMed
  19. Ferwerda M , van Beugen S , van Middendorp H , et al . Tailored, Therapist-Guided Internet-based cognitive behavioral therapy compared to care as usual for patients with rheumatoid arthritis: economic evaluation of a randomized controlled trial . J Med Internet Res 2018 ; 20 : e260 . 10.2196/jmir.9997 30309835 PMC6231867 DOI PubMed
  20. Luszczynska A , Scholz U , Schwarzer R . The general self-efficacy scale: multicultural validation studies . J Psychol 2005 ; 139 : 439 – 57 . 10.3200/JRLP.139.5.439-457 16285214 DOI PubMed
  21. Bay LT , Ellingsen T , Giraldi A , et al . "To be lonely in your own loneliness": The interplay between self-perceived loneliness and rheumatoid arthritis in everyday life: A qualitative study . Musculoskeletal Care 2020 ; 18 : 450 – 8 . 10.1002/msc.1480 32491275 DOI PubMed
  22. Souliotis K , Agapidaki E , Peppou LE , et al . Assessing patient organization participation in health policy: a comparative study in France and Italy . Int J Health Policy Manag 2018 ; 7 : 48 – 58 . 10.15171/ijhpm.2017.44 29325402 PMC5745867 DOI PubMed
  23. Akrich M , Nunes J , Paterson F . The dynamics of patient organizations in Europe . 9th ed . Paris : Presses des Mines , 2008 . http://books.openedition.org/pressesmines/1587
  24. Barlow JH , Pennington DC , Bishop PE . Patient education leaflets for people with rheumatoid arthritis: a controlled study . Psychol Health Med 1997 ; 2 : 221 – 35 . 10.1080/13548509708400580 DOI
  25. Barlow JH , Wright CC . Knowledge in patients with rheumatoid arthritis: a longer term follow-up of a randomized controlled study of patient education leaflets . Br J Rheumatol 1998 ; 37 : 373 – 6 . 10.1093/rheumatology/37.4.373 9619885 DOI PubMed
  26. Hill J , Bird H , Johnson S . Effect of patient education on adherence to drug treatment for rheumatoid arthritis: a randomised controlled trial . Ann Rheum Dis 2001 ; 60 : 869 – 75 . 11502614 PMC1753835 PubMed
  27. Knittle K , De Gucht V , Hurkmans E , et al . Targeting motivation and self-regulation to increase physical activity among patients with rheumatoid arthritis: a randomised controlled trial . Clin Rheumatol 2015 ; 34 : 231 – 8 . 10.1007/s10067-013-2425-x 24213780 DOI PubMed
  28. van Lankveld W , van Helmond T , Näring G , et al . Partner participation in cognitive-behavioral self-management group treatment for patients with rheumatoid arthritis . J Rheumatol 2004 ; 31 : 1738 – 45 . 15338493 PubMed
  29. Niedermann K , de Bie RA , Kubli R , et al . Effectiveness of individual resource-oriented joint protection education in people with rheumatoid arthritis. A randomized controlled trial . Patient Educ Couns 2011 ; 82 : 42 – 8 . 10.1016/j.pec.2010.02.014 20451345 DOI PubMed
  30. Niedermann K , Buchi S , Ciurea A , et al . Six and 12 months' effects of individual joint protection education in people with rheumatoid arthritis: a randomized controlled trial . Scand J Occup Ther 2012 ; 19 : 360 – 9 . 10.3109/11038128.2011.611820 21936735 DOI PubMed
  31. Ritschl V , Stamm TA , Aletaha D , et al . 2020 EULAR points to consider for the prevention, screening, assessment and management of non-adherence to treatment in people with rheumatic and musculoskeletal diseases for use in clinical practice . Ann Rheum Dis 2021 ; 80 : 707 – 13 . 10.1136/annrheumdis-2020-218986 33355152 DOI PubMed
  32. Zangi HA , Ndosi M , Adams J , et al . EULAR recommendations for patient education for people with inflammatory arthritis . Ann Rheum Dis 2015 ; 74 : 954 – 62 . 10.1136/annrheumdis-2014-206807 25735643 DOI PubMed
  33. Barsky AJ , Ahern DK , Orav EJ , et al . A randomized trial of three psychosocial treatments for the symptoms of rheumatoid arthritis . Semin Arthritis Rheum 2010 ; 40 : 222 – 32 . 10.1016/j.semarthrit.2010.04.001 20621334 PMC2993818 DOI PubMed
  34. El Miedany Y , El Gaafary M , El Arousy N , et al . Arthritis education: the integration of patient-reported outcome measures and patient self-management . Clin Exp Rheumatol 2012 ; 30 : 899 – 904 . 22992291 PubMed
  35. Shigaki CL , Smarr KL , Siva C , et al . RAHelp: an online intervention for individuals with rheumatoid arthritis . Arthritis Care Res 2013 ; 65 : 1573 – 81 . 10.1002/acr.22042 23666599 DOI PubMed
  36. Lumley MA , Keefe FJ , Mosley-Williams A , et al . The effects of written emotional disclosure and coping skills training in rheumatoid arthritis: a randomized clinical trial . J Consult Clin Psychol 2014 ; 82 : 644 – 58 . 10.1037/a0036958 24865870 PMC4115002 DOI PubMed
  37. Hewlett S , Ambler N , Almeida C , et al . Self-Management of fatigue in rheumatoid arthritis: a randomised controlled trial of group cognitive-behavioural therapy . Ann Rheum Dis 2011 ; 70 : 1060 – 7 . 10.1136/ard.2010.144691 21540202 PMC3086034 DOI PubMed
  38. Hammond A , Bryan J , Hardy A . Effects of a modular behavioural arthritis education programme: a pragmatic parallel-group randomized controlled trial . Rheumatology 2008 ; 47 : 1712 – 8 . 10.1093/rheumatology/ken380 18815153 DOI PubMed
  39. Evers AWM , Kraaimaat FW , van Riel PLCM , et al . Tailored cognitive-behavioral therapy in early rheumatoid arthritis for patients at risk: a randomized controlled trial . Pain 2002 ; 100 : 141 – 53 . 10.1016/S0304-3959(02)00274-9 12435467 DOI PubMed
  40. Basler HD , Rehfisch HP . Cognitive-Behavioral therapy in patients with ankylosing spondylitis in a German self-help organization . J Psychosom Res 1991 ; 35 : 345 – 54 . 10.1016/0022-3999(91)90089-7 1710669 DOI PubMed
  41. Freeman K , Hammond A , Lincoln NB . Use of cognitive-behavioural arthritis education programmes in newly diagnosed rheumatoid arthritis . Clin Rehabil 2002 ; 16 : 828 – 36 . 10.1191/0269215502cr565oa 12501944 DOI PubMed
  42. Du S , Yuan C , Xiao X , et al . Self-Management programs for chronic musculoskeletal pain conditions: a systematic review and meta-analysis . Patient Educ Couns 2011 ; 85 : e299 – 310 . 10.1016/j.pec.2011.02.021 21458196 DOI PubMed
  43. Cramp F , Hewlett S , Almeida C , et al . Non-Pharmacological interventions for fatigue in rheumatoid arthritis . Cochrane Database Syst Rev 2013 ; 8 : Cd008322 . 10.1002/14651858.CD008322.pub2 PMC11748118 23975674 DOI PubMed
  44. Cramer H , Lauche R , Langhorst J , et al . Yoga for rheumatic diseases: a systematic review . Rheumatology 2013 ; 52 : 2025 – 30 . 10.1093/rheumatology/ket264 23934220 DOI PubMed
  45. Dagfinrud H , Kvien TK , Hagen KB . Physiotherapy interventions for ankylosing spondylitis . Cochrane Database Syst Rev 2008 ; 1 : Cd002822 . 10.1002/14651858.CD002822.pub3 PMC8453259 18254008 DOI PubMed
  46. Mudano AS , Tugwell P , Wells GA , et al . Tai chi for rheumatoid arthritis . Cochrane Database Syst Rev 2019 ; 9 : CD004849 . 10.1002/14651858.CD004849.pub2 31553478 PMC6759565 DOI PubMed
  47. Pécourneau V , Degboé Y , Barnetche T , et al . Effectiveness of exercise programs in ankylosing spondylitis: a meta-analysis of randomized controlled trials . Arch Phys Med Rehabil 2018 ; 99 : 383 – 9 . 10.1016/j.apmr.2017.07.015 28860095 DOI PubMed
  48. Lopes S , Costa S , Mesquita C , et al . [Home based and group based exercise programs in patients with ankylosing spondylitis: systematic review] . Acta Reumatol Port 2016 ; 41 : 104 – 11 . 27606470 PubMed
  49. Santos EJF , Duarte C , Marques A , et al . Effectiveness of non-pharmacological and non-surgical interventions for rheumatoid arthritis: an umbrella review . JBI Database System Rev Implement Rep 2019 ; 17 : 1494 – 531 . 10.11124/JBISRIR-D-18-00020 31169776 DOI PubMed
  50. Rausch Osthoff A-K , Niedermann K , Braun J , et al . 2018 EULAR recommendations for physical activity in people with inflammatory arthritis and osteoarthritis . Ann Rheum Dis 2018 ; 77 : 1251 – 60 . 10.1136/annrheumdis-2018-213585 29997112 DOI PubMed
  51. Metsios GS , Kitas GD . Physical activity, exercise and rheumatoid arthritis: effectiveness, mechanisms and implementation . Best Pract Res Clin Rheumatol 2018 ; 32 : 669 – 82 . 10.1016/j.berh.2019.03.013 31203925 DOI PubMed
  52. Brown Z , Metcalf R , Bednarz J , et al . Modifiable lifestyle factors associated with response to treatment in early rheumatoid arthritis . ACR Open Rheumatol 2020 ; 2 : 371 – 7 . 10.1002/acr2.11132 32453505 PMC7301874 DOI PubMed
  53. Sokolove J , Wagner CA , Lahey LJ , et al . Increased inflammation and disease activity among current cigarette smokers with rheumatoid arthritis: a cross-sectional analysis of US veterans . Rheumatology 2016 ; 55 : 1969 – 77 . 10.1093/rheumatology/kew285 27477806 PMC5088624 DOI PubMed
  54. Nikiphorou E , Norton S , Young A , et al . The association of obesity with disease activity, functional ability and quality of life in early rheumatoid arthritis: data from the early rheumatoid arthritis Study/Early rheumatoid arthritis network UK prospective cohorts . Rheumatology 2018 ; 57 : 1194 – 202 . 10.1093/rheumatology/key066 29590474 DOI PubMed
  55. Fragoulis GE , Panayotidis I , Nikiphorou E . Cardiovascular risk in rheumatoid arthritis and mechanistic links: from pathophysiology to treatment . Curr Vasc Pharmacol 2020 ; 18 : 431 – 46 . 10.2174/1570161117666190619143842 31258091 DOI PubMed
  56. Roubille C , Richer V , Starnino T , et al . Evidence-Based recommendations for the management of comorbidities in rheumatoid arthritis, psoriasis, and psoriatic arthritis: expert opinion of the Canadian Dermatology-Rheumatology comorbidity initiative . J Rheumatol 2015 ; 42 : 1767 – 80 . 10.3899/jrheum.141112 26178281 DOI PubMed
  57. Gualtierotti R , Ughi N , Marfia G , et al . Practical management of cardiovascular comorbidities in rheumatoid arthritis . Rheumatol Ther 2017 ; 4 : 293 – 308 . 10.1007/s40744-017-0068-0 28752316 PMC5696280 DOI PubMed
  58. Lwin MN , Serhal L , Holroyd C , et al . Rheumatoid arthritis: the impact of mental health on disease: a narrative review . Rheumatol Ther 2020 ; 7 : 457 – 71 . 10.1007/s40744-020-00217-4 32535834 PMC7410879 DOI PubMed
  59. Santos EF , Duarte CM , Ferreira RO , et al . Multifactorial explanatory model of depression in patients with rheumatoid arthritis: a structural equation approach . Clin Exp Rheumatol 2019 ; 37 : 641 – 8 . 30418126 PubMed
  60. He Y , Zhang M , Lin EHB , et al . Mental disorders among persons with arthritis: results from the world mental health surveys . Psychol Med 2008 ; 38 : 1639 – 50 . 10.1017/S0033291707002474 18298879 PMC2736852 DOI PubMed
  61. Astin JA , Beckner W , Soeken K , et al . Psychological interventions for rheumatoid arthritis: a meta-analysis of randomized controlled trials . Arthritis Rheum 2002 ; 47 : 291 – 302 . 10.1002/art.10416 12115160 DOI PubMed
  62. DiRenzo D , Crespo-Bosque M , Gould N , et al . Systematic review and meta-analysis: Mindfulness-Based interventions for rheumatoid arthritis . Curr Rheumatol Rep 2018 ; 20 : 75 . 10.1007/s11926-018-0787-4 30338418 PMC6233984 DOI PubMed
  63. Knittle K , Maes S , de Gucht V , Gucht de . Psychological interventions for rheumatoid arthritis: examining the role of self-regulation with a systematic review and meta-analysis of randomized controlled trials . Arthritis Care Res 2010 ; 62 : 1460 – 72 . 10.1002/acr.20251 20506175 DOI PubMed
  64. Dissanayake RK , Bertouch JV . Psychosocial interventions as adjunct therapy for patients with rheumatoid arthritis: a systematic review . Int J Rheum Dis 2010 ; 13 : 324 – 34 . 10.1111/j.1756-185X.2010.01563.x 21199467 DOI PubMed
  65. van Grieken RA , van Tricht MJ , Koeter MWJ , et al . The use and helpfulness of self-management strategies for depression: the experiences of patients . PLoS One 2018 ; 13 : e0206262-e . 10.1371/journal.pone.0206262 30359444 PMC6201928 DOI PubMed
  66. Ware JE , Snow KK , Kosinski M . New England Medical Center Hospital, health institute. . In: SF-36 health survey: manual and interpretation guide . 3rd ed . Boston : Health Institute, New England Medical Center , 2004 .
  67. Kroenke K , Spitzer RL , Williams JB . The PHQ-9: validity of a brief depression severity measure . J Gen Intern Med 2001 ; 16 : 606 – 13 . 10.1046/j.1525-1497.2001.016009606.x 11556941 PMC1495268 DOI PubMed
  68. European League Against Rheumatism (EULAR) . The EULAR strategy: 2018-2023: EULAR; , 2018 . Available: https://www.eular.org/eular_strategy_2018.cfm
  69. Kurt E , Özdilli K , Yorulmaz H . Body image and self-esteem in patients with rheumatoid arthritis . Noro Psikiyatr Ars 2013 ; 50 : 202 – 8 . 10.4274/npa.y6195 28360544 PMC5363436 DOI PubMed
  70. Verstappen SMM . Rheumatoid arthritis and work: the impact of rheumatoid arthritis on absenteeism and presenteeism . Best Pract Res Clin Rheumatol 2015 ; 29 : 495 – 511 . 10.1016/j.berh.2015.06.001 26612244 DOI PubMed
  71. Yoshida K , Stephens M . Living with rheumatoid arthritis. strategies that support independence and autonomy in everyday life . Physiother Theory Pract 2004 ; 20 : 221 – 31 . 10.1080/09593980490887984 DOI
  72. Steinhubl SR , Muse ED , Topol EJ . The emerging field of mobile health . Sci Transl Med 2015 ; 7 : 283rv3 . 10.1126/scitranslmed.aaa3487 PMC4748838 25877894 DOI PubMed
  73. Bradway M , Årsand E , Grøttland A . Mobile health: empowering patients and driving change . Trends Endocrinol Metab 2015 ; 26 : 114 – 7 . 10.1016/j.tem.2015.01.001 25727462 DOI PubMed
  74. Najm A , Nikiphorou E , Kostine M , et al . EULAR points to consider for the development, evaluation and implementation of mobile health applications Aiding self-management in people living with rheumatic and musculoskeletal diseases . RMD Open 2019 ; 5 : e001014-e 10.1136/rmdopen-2019-001014 31565245 PMC6744072 DOI PubMed
  75. Opava CH , Carlsson A . The role of patient organisations in musculoskeletal care . Best Pract Res Clin Rheumatol 2012 ; 26 : 399 – 407 . 10.1016/j.berh.2012.05.003 22867934 DOI PubMed
  76. Thirsk LM , Clark AM . What is the 'self' in chronic disease self-management? Int J Nurs Stud 2014 ; 51 : 691 – 3 . 10.1016/j.ijnurstu.2013.10.008 24216597 DOI PubMed
  77. Udlis KA . Self-Management in chronic illness: concept and dimensional analysis . J Nurs Healthc Chronic Illn 2011 ; 3 : 130 – 9 . 10.1111/j.1752-9824.2011.01085.x DOI
  78. Ekman I , Swedberg K , Taft C , et al . Person-centered care--ready for prime time . Eur J Cardiovasc Nurs 2011 ; 10 : 248 – 51 . 10.1016/j.ejcnurse.2011.06.008 21764386 DOI PubMed
  79. McCormack B , Borg M , Cardiff S , et al . Person-centredness – the ‘state’ of the art . IPDJ 2015 ; 5 : 1 – 15 . 10.19043/ipdj.5SP.003 DOI
  80. de Wit M , Hochberg MC . The Patient Perspective . In: Gravallese EM , Silman AJ , Weinblatt ME , et al , eds. Rheumatology . 7th ed . Elsevier , 2017 : 409 – 12 .
  81. Voshaar MJH , Nota I , van de Laar MAFJ , et al . Patient-Centred care in established rheumatoid arthritis . Best Pract Res Clin Rheumatol 2015 ; 29 : 643 – 63 . 10.1016/j.berh.2015.09.007 26697772 DOI PubMed
  82. Chewning B , Bylund CL , Shah B , et al . Patient preferences for shared decisions: a systematic review . Patient Educ Couns 2012 ; 86 : 9 – 18 . 10.1016/j.pec.2011.02.004 21474265 PMC4530615 DOI PubMed
  83. Ferreira RJO , Santos EJF , de Wit M , et al . Shared decision-making in people with chronic disease: integrating the biological, social and lived experiences is a key responsibility of nurses . Musculoskeletal Care 2020 ; 18 : 84 – 91 . 10.1002/msc.1443 31837252 DOI PubMed
  84. Litchfield I , Bentham L , Hill A , et al . The impact of status and social context on health service co-design: an example from a collaborative improvement initiative in UK primary care . BMC Med Res Methodol 2018 ; 18 : 136 . 10.1186/s12874-018-0608-5 30445914 PMC6240286 DOI PubMed
  85. Coles E , Anderson J , Maxwell M , et al . The influence of contextual factors on healthcare quality improvement initiatives: a realist review . Syst Rev 2020 ; 9 : 94 . 10.1186/s13643-020-01344-3 32336290 PMC7184709 DOI PubMed

Conditions covered

Inflammatory arthritisSelf-management strategies

Reproduced for free educational use under the licence shown above. WhiteCoat Pro is not affiliated with or endorsed by the authors, the publisher or the issuing organisation. Always check the original document for the current version.